Table 3.

Comparison between both groups regarding short-term morbidity and mortality after propensity matching

	No Ivabradine (n = 342)	Ivabradine (n = 342)	P-value
Hospital stay (days)	6.5 ± 5.3	5.3 ± 2.3	0.014*
Re-hospitalization (30 days)	2 (0.6)	2 (0.6)	1
Death (30 days)	0 (0)	0 (0)	1
Re-hospitalization (180 days)	9 (2.6)	10 (2.9)	0.81
Death (180 days)	2 (0.6)	1 (0.3)	0.56

Data are represented in number (%) or mean ± S.D.

^*Significant P-value < 0.05.